Notably, the VEGF-VEGFR-activated pathway network in the endothelium included the venous EC-specific proangiogenic gene PLVAP, suggesting that the angiogenesis-promoting transcriptomic changes observed in the ECs may be initiated by the tumor cells (Fig. 6c). This evidence concerns the gene PLVAP and neoplasm.